Fig. 3From: I-125 seeds with chemotherapy for progressive non-small-cell lung cancer after first-line treatment: a meta-analysisThe pooled results of a CR rates, b TR rates, c DC rates, d PFS, e OS, f myelosuppression rates, and g gastrointestinal response rates between 2 groupsBack to article page